MedTrace Logo

Canadian eCLIPs™ Safety and Feasibility Study Protocol

NCT01957683 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2019-02-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and feasibility of the eCLIPs™ Family of Products for the treatment of unruptured intracranial bifurcation aneurysms in conjunction with embolization coils.

Conditions

  • Intracranial Aneurysms

Interventions

DEVICE

eCLIPs™ Family of Products

Safety and feasibility of the eCLIPs™ Family of Products for the treatment of unruptured bifurcation intracranial aneurysms

Sponsors & Collaborators

  • Evasc Medical Systems Corp.

    lead INDUSTRY

Principal Investigators

  • Michael EB Kelly, PhD, MD, FRCSC, FACS · Royal University Hospital, Saskatoon, Saskatchewan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2021-12-31
Completion
2022-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01957683 on ClinicalTrials.gov